Cormorant Global Healthcare Master Fund, LP

(See below) at ENVIVIO INC · on record since Jun 8, 2023
10% owner at EyePoint, Inc. · on record since Dec 12, 2023
10% owner at MoonLake Immunotherapeutics · on record since Oct 10, 2023
10% owner at Corbus Pharmaceuticals Holdings, Inc. · on record since Jan 30, 2024
10% owner at OnKure Therapeutics, Inc. · on record since Oct 15, 2024
Former 10% Owner at OnKure Therapeutics, Inc. · on record since May 19, 2025
Former 10% Holder at Biomea Fusion, Inc. · on record since Aug 1, 2025
Former 10% Owner at EyePoint, Inc. · on record since Dec 8, 2025
Former 10% Owner at MoonLake Immunotherapeutics · on record since Oct 1, 2025
10% owner at Elevate, Inc. · on record since Jun 24, 2021
Former 10% Owner at Verve Therapeutics, Inc. · on record since Jun 23, 2021
10% owner at Tyra Biosciences, Inc. · on record since Sep 14, 2021
10% owner at Biomea Fusion, Inc. · on record since Apr 22, 2021
10% owner at Rain Oncology Inc. · on record since Apr 22, 2021
Former 10% Owner at BRIGHT MINDS BIOSCIENCES INC. · on record since Apr 30, 2026
10% owner at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Nov 23, 2016
10% owner at Verve Therapeutics, Inc. · on record since Jun 16, 2021
10% owner at Cellectar Biosciences, Inc. · on record since Sep 5, 2014
10% owner at · on record since Jun 13, 2016
10% owner at · on record since Aug 6, 2026
10% owner at · on record since Nov 14, 2017
10% owner at · on record since May 31, 2018
10% owner at · on record since Jun 27, 2018
10% owner at · on record since Jul 20, 2018
10% owner at · on record since Oct 30, 2018
Former 10% Owner at · on record since Apr 1, 2021
10% owner at · on record since Jun 25, 2020
10% owner at · on record since Jun 18, 2020
10% owner at · on record since Jul 29, 2021
10% owner at · on record since Nov 23, 2020
10% owner at · on record since Dec 22, 2020
10% owner at · on record since Nov 5, 2020
10% owner at · on record since Mar 25, 2021
10% owner at · on record since Mar 18, 2021
10% owner at · on record since Jun 30, 2021
10% owner at · on record since Jun 29, 2021
Former 10% Owner at · on record since Apr 29, 2021
10% owner at · on record since Jul 28, 2021
10% owner at · on record since Jul 22, 2021
Former 10% Owner at · on record since Sep 21, 2021
Former 10% Owner at · on record since Jul 7, 2021
Former 10% Owner at · on record since Aug 4, 2021
Former 10% Owner at · on record since Oct 27, 2021
10% owner at · on record since Oct 20, 2021
Former 10% Owner at · on record since Oct 15, 2021
10% owner at · on record since Oct 7, 2021
Former 10% Owner at · on record since Jan 13, 2022
10% owner at · on record since Jan 6, 2022
Director at · on record since Dec 21, 2022
10% owner at · on record since Mar 16, 2023
10% owner at · on record since Oct 17, 2024
Former 10% Owner at · on record since Mar 18, 2021

Insider trading activity of Cormorant Global Healthcare Master Fund, LP

Transactions on record: 71; since Nov 14, 2017

Open-market buys: 42; $117M

Open-market sells: 11; $49.7M

Companies traded: 14; last filing Oct 1, 2025

Figures computed from official regulatory filings — .

Companies where Cormorant Global Healthcare Master Fund, LP has traded

5 tx · $46.9M · Oct 1, 2025
1 tx · $48.4K · May 14, 2025
11 tx · $3.2M · Oct 17, 2024
6 tx · $7M · Sep 24, 2024
2 tx · $12M · Jun 13, 2024
19 tx · $52.4M · Apr 22, 2024
5 tx · $2.8M · Mar 18, 2024
2 tx · Jan 13, 2022
2 tx · Aug 4, 2021
3 tx · $7M · Jul 7, 2021
3 tx · $5.2M · Jun 23, 2021
4 tx · $7.1M · Mar 18, 2021
4 tx · $8.1M · Nov 23, 2020
4 tx · $15M · Nov 14, 2017

Track record of Cormorant Global Healthcare Master Fund, LP

Statistical track record

Free

Open-market buys: 42

Last buy: Oct 16, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Transaction history of Cormorant Global Healthcare Master Fund, LP

Co-insiders of Cormorant Global Healthcare Master Fund, LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-5,827	6.96 USD	$40.6K	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-232,460	8.40 USD	$2M	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-3,390,943	7.58 USD	$25.7M	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-2,800,000	6.61 USD	$18.5M	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-70,748	9.38 USD	$663.6K	SEC
OnKure Therapeutics, Inc.Listing on record	May 14, 2025	Sell	-24,300	1.99 USD	$48.4K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	63,173	5.92 USD	$374K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	3,107	25.22 USD	$78.4K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	2,600	8.80 USD	$22.9K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	33,343	6.42 USD	$214.1K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	2,700	9.26 USD	$25K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	238,097	4.53 USD	$1.1M	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	8,900	7.31 USD	$65.1K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	7,150	24.03 USD	$171.8K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	39,743	23.22 USD	$922.8K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	4,609	12.35 USD	$56.9K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	19,169	11.72 USD	$224.7K	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	139,551	20.42 USD	$2.8M	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	45,085	17.48 USD	$788.1K	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	25,943	18.36 USD	$476.3K	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	66,088	19.61 USD	$1.3M	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	47,564	21.47 USD	$1M	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	25,769	22.23 USD	$572.8K	SEC
Biomea Fusion, Inc.Listing on record	Jun 13, 2024	AwardD (derivative)	51,025	0.00 USD	—	SEC
EyePoint, Inc.Listing on record	Apr 22, 2024	Buy	186,521	18.90 USD	$3.5M	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-5,827	6.96 USD	$40.6K	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-232,460	8.40 USD	$2M	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-3,390,943	7.58 USD	$25.7M	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-2,800,000	6.61 USD	$18.5M	SEC
MoonLake ImmunotherapeuticsListing on record	Oct 1, 2025	Sell	-70,748	9.38 USD	$663.6K	SEC
OnKure Therapeutics, Inc.Listing on record	May 14, 2025	Sell	-24,300	1.99 USD	$48.4K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	63,173	5.92 USD	$374K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	3,107	25.22 USD	$78.4K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	2,600	8.80 USD	$22.9K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	33,343	6.42 USD	$214.1K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	2,700	9.26 USD	$25K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	238,097	4.53 USD	$1.1M	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	8,900	7.31 USD	$65.1K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	7,150	24.03 USD	$171.8K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	39,743	23.22 USD	$922.8K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	4,609	12.35 USD	$56.9K	SEC
BRIGHT MINDS BIOSCIENCES INC.Listing on record	Oct 17, 2024	Buy	19,169	11.72 USD	$224.7K	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	139,551	20.42 USD	$2.8M	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	45,085	17.48 USD	$788.1K	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	25,943	18.36 USD	$476.3K	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	66,088	19.61 USD	$1.3M	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	47,564	21.47 USD	$1M	SEC
Corbus Pharmaceuticals Holdings, Inc.Listing on record	Sep 24, 2024	Buy	25,769	22.23 USD	$572.8K	SEC
Biomea Fusion, Inc.Listing on record	Jun 13, 2024	AwardD (derivative)	51,025	0.00 USD	—	SEC
EyePoint, Inc.Listing on record	Apr 22, 2024	Buy	186,521	18.90 USD	$3.5M	SEC